Literature DB >> 16890311

An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon?

Nicoletta Botto1, Silverio Sbrana, Giuseppe Trianni, Maria Grazia Andreassi, Marcello Ravani, Antonio Rizza, Anees Al-Jabri, Cataldo Palmieri, Sergio Berti.   

Abstract

BACKGROUND: Distal protection devices have been shown to reduce the incidence of "no flow" phenomenon during primary percutaneous coronary intervention (PCI). So far, it has not been well clarified which mechanism is mainly involved in distal coronary protection. AIM: To investigate the activation state of leukocytes and platelets locally present within the blood from the site of coronary occlusion.
METHODS: Ten patients with acute myocardial infarction (AMI) underwent primary PCI with an embolization protection device and aspiration catheter (PercuSurge GuardWire) were included. The following functional parameters: a) monocyte and neutrophils surface molecules; b) platelet surface activatory antigens; c) leukocytes-platelet conjugates were studied by flow cytometry in blood obtained from the site of coronary occlusion and from peripheral femoral artery.
RESULTS: The leukocyte-platelet adhesion index was significantly higher in the aspirated blood at the site of coronary occlusion than in the peripheral arterial blood for both monocytes (0.226+/-0.04 vs. 0.084+/-0.01; p=0.004) and neutrophils (1.372+/-0.3 vs. 0.524+/-0.1; p=0.02). Moreover, the volume of coaggregates exhibited a significant increase in coronary blood for both populations (p=0.02 for monocytes and for neutrophils). Interestingly, a significant up-regulation of the adhesive molecule CD18 was observed in coronary blood respect to systemic circulation either in monocytes (p=0.01) than in neutrophils (p=0.003). A significant up-regulation of monocyte (HLA-DR) and neutrophil (CD66b) activatory molecules expression was also observed in the aspirated coronary compared to peripheral artery blood (p=0.02 and p=0.03 for HLA-DR and CD66b, respectively).
CONCLUSIONS: These data indicate an increased leukocyte-platelet functional interaction in AMI at the site of plaque rupture relative to the systemic circulation, which may be one of the pathogenetic mechanisms responsible for myocardial "no-reflow" phenomenon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890311     DOI: 10.1016/j.ijcard.2006.04.060

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Blood cell counts and their correlation with creatine kinase and C-reactive protein in patients with acute myocardial infarction.

Authors:  Haseeb A Khan; Abdullah S Alhomida; Samia H Sobki; Abdulrahman Al Moghairi; Hatim El Koronki
Journal:  Int J Clin Exp Med       Date:  2012-01-15

2.  Association between peak neutrophil count, clopidogrel loading dose, and left ventricular systolic function in patients with primary percutaneous coronary intervention.

Authors:  Xinyu Wang; Haiyi Yu; Zhaoping Li; Liuning Li; Youyi Zhang; Wei Gao
Journal:  Mediators Inflamm       Date:  2014-07-24       Impact factor: 4.711

3.  Neutrophil stunning by metoprolol reduces infarct size.

Authors:  Jaime García-Prieto; Rocío Villena-Gutiérrez; Mónica Gómez; Esther Bernardo; Andrés Pun-García; Inés García-Lunar; Georgiana Crainiciuc; Rodrigo Fernández-Jiménez; Vinatha Sreeramkumar; Rafael Bourio-Martínez; José M García-Ruiz; Alfonso Serrano Del Valle; David Sanz-Rosa; Gonzalo Pizarro; Antonio Fernández-Ortiz; Andrés Hidalgo; Valentín Fuster; Borja Ibanez
Journal:  Nat Commun       Date:  2017-04-18       Impact factor: 14.919

4.  Usefulness of white blood cell count to mean platelet volume ratio in the prediction of SYNTAX score in patients with non-ST elevation myocardial infarction.

Authors:  Serkan Sivri; Erdogan Sokmen; Mustafa Celik; Sinan Cemgil Ozbek; Alp Yildirim; Yalcin Boduroglu
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

5.  Impact of the caFFR-Guided Functional SYNTAX Score on Ventricular Tachycardia/Fibrillation Development in Patients With Acute Myocardial Infarction.

Authors:  Jiazhi Pan; Qiuxia Zhang; Li Lei; Yaode Chen; Guodong Li; Hongbin Liang; Junyan Lu; Xinlu Zhang; Yongzhen Tang; Jun Pu; Yining Yang; Dapeng Mo; Jiancheng Xiu
Journal:  Front Cardiovasc Med       Date:  2022-04-12

6.  Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: An Observational Study.

Authors:  Yen-Ting Yeh; Cheng-Wei Liu; Ai-Hsien Li; Shin-Rong Ke; Yuan-Hung Liu; Kuo-Chin Chen; Pen-Chih Liao; Yen-Wen Wu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

7.  Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts.

Authors:  Mohammad Hashemi-Jazi; Sayed Mojtaba Hosseini; Ali Gholamrezaei
Journal:  ARYA Atheroscler       Date:  2017-09

8.  Prognostic value of blood count parameters in patients with acute coronary syndrome.

Authors:  Arsalan Majeed Adam; Ather Hasan Rizvi; Amna Haq; Rabia Naseem; Aiman Rehan; Ali Tariq Shaikh; Abdul Haseeb Abbas; Ansab Godil; Arif Ali; Muhammad Saad Ali Mallick; Muhammad Shahzeb Khan; Muhammad Nawaz Lashari
Journal:  Indian Heart J       Date:  2017-06-30

9.  Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.

Authors:  Sascha Marx; Maximilian Splittstöhser; Frederik Kinnen; Eileen Moritz; Christy Joseph; Sebastian Paul; Heiko Paland; Carolin Seifert; Madlen Marx; Andreas Böhm; Edzard Schwedhelm; Kerstin Holzer; Stephan Singer; Christoph A Ritter; Sandra Bien-Möller; Henry W S Schroeder; Bernhard H Rauch
Journal:  Oncotarget       Date:  2018-05-25

10.  Investigation of a Thromboxane A2 Receptor-Based Vaccine for Managing Thrombogenesis.

Authors:  Fatima Z Alshbool; Zubair A Karim; Enma V Paez Espinosa; Olivia A Lin; Fadi T Khasawneh
Journal:  J Am Heart Assoc       Date:  2018-06-23       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.